EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate

Jang Hee Han, Dae Hyuk Chung, Min Chul Cho, Ja Hyeon Ku, Chang Wook Jeong, Cheol Kwak, Jae-Seung Paick, Seung-June Oh iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0278931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Jang Hee Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Seoul National University Hospital, Seoul, South Korea. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Lasers, Solid-State, Prostatic Neoplasms, Transurethral Resection of Prostate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

There is no consensus on the management plan for incidental prostate cancer (IPCa) after holmium laser enucleation of the prostate (HoLEP). This study aims to investigate the natural course of this disease and suggest appropriate treatment in real clinical practice.

Methods

The medical records of a prospective cohort of patients with LUTS/BPH who underwent HoLEP between July 2008 and December 2020 at Seoul National University Hospital were retrospectively reviewed. Patients who underwent HoLEP for palliative purpose of prostate cancer control were excluded. The natural history of IPCa was assessed by the clinician in a descriptive manner for each treatment option.

Results

Among 2630 patients, 141 (5.4%) were diagnosed with IPCa after HoLEP. Pathologic T stage and magnetic resonance imaging results were highly associated with the physician’s primary treatment decision-making for IPCa. Active surveillance (AS) was performed in 80% of patients, of whom 90% underwent follow-up without intervention, while the remaining 10% underwent deferred active treatment with a median follow-up of 46.3 months due to International Society of Urological Pathology grade group upgrading or increasing core involvement percentage. Meanwhile, 20% of patients underwent immediate active treatment. With a median follow-up period of 88.3 months after treatment, only one of 25 patients had biochemical recurrence.

Conclusions

The incidence of IPCa after HoLEP was 5.4%, and among these, approximately 20% proceeded with immediate definitive therapy and an additional 6% ultimately received definitive therapy within a median of 4 years of AS but showed excellent oncological outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaLasers, Solid-StateProstatic NeoplasmsTransurethral Resection of ProstateLaser TherapyMaleHumansProstateRetrospective StudiesProspective StudiesHolmiumTreatment OutcomeCyanoacrylates

Substanzen

Holmiumisopropyl cyanoacrylateCyanoacrylates

Autor:innen und Institutionen

  • Department of Urology, Seoul National University Hospital, Seoul, South Korea.
  • Department of Urology, SMG-SNU Boramae Medical Center, Seoul, South Korea.
  • Department of Urology, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Urology, Mediplex Sejong Hospital, Seoul, South Korea.

ORCID-Profile: Seung-June Oh

Zitieren

APA

Han, J. H., Chung, D. H., Cho, M. C., Ku, J. H., Jeong, C. W., Kwak, C., Paick, J. S., & Oh, S. J. (2023). Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate. PLOS ONE. https://doi.org/10.1371/journal.pone.0278931

Vancouver

Han JH, Chung DH, Cho MC, Ku JH, Jeong CW, Kwak C, et al. Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate. PLOS ONE. 2023. doi:10.1371/journal.pone.0278931

BibTeX
@article{Han2023,
  author = {Han, Jang Hee and Chung, Dae Hyuk and Cho, Min Chul and Ku, Ja Hyeon and Jeong, Chang Wook and Kwak, Cheol and Paick, Jae-Seung and Oh, Seung-June},
  title = {Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0278931}
}
Kostenlos starten →